Chemokines in cartilage degradation

Clinical Orthopaedics and Related Research

Volumn 427, Issue SUPPL., 2004, Pages

  Borzì, Rosa Maria ^a   Mazzetti, Ilaria ^a   Marcu, Kenneth B ^b,c   Facchini, Andrea ^a,d  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b Applied Biomedical Research Center   (Italy)

^c STONY BROOK UNIVERSITY   (United States)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR2; COLLAGENASE 3; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; N ACETYL BETA GLUCOSAMINIDASE; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL DEATH; CONFERENCE PAPER; ENZYME RELEASE; HUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 5444261666     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000143805.64755.4f     Document Type: Conference Paper

References (88)

1. Alaaeddine N, Olee T, Hashimoto S, Creighton-Achermann L, Lotz M: Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation. Arthritis Rheum 44:1633-1643, 2001.
2. Anest V, Hanson JL, Cogswell PC, et al: A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. Nature 423:659-663, 2003.
3. Attur MG, Dave M, Akamatsu M, Katoh M, Amin AR: Osteoarthritis or osteoarthrosis: the definition of inflammation becomes a semantic issue in the genomic era of molecular medicine. Osteoarthritis Cartilage 10:1-4, 2002.
4. Bacon K, Baggiolini M, Broxmeyer H, et al: Chemokine/chemokine receptor nomenclature. J Interferon Cytokine Res 22:1067-1068, 2002.
5. Baggiolini M: Chemokines in pathology and medicine. J Intern Med 250:91-104, 2001.
6. Baici A, Lang A, Horler D, Knopfel M: Cathepsin B as a marker of the dedifferentiated chondrocyte phenotype. Ann Rheum Dis 47:684-691, 1988.
7. Baici A, Lang A, Hörler D, Kissling R, Merlin C: Cathepsin B in osteoarthritis: cytochemical and histochemical analysis of human femoral head cartilage. Ann Rheum Dis 54:289-297, 1995.
8. Bailey AJ, Mansell JP: Do subchondral bone changes exacerbate or precede articular cartilage destruction in osteoarthritis of the elderly? Gerontology 43:296-304, 1997.
9. Berardi S, Lang A, Kostoulas G, et al: Alternative messenger RNA splicing and enzyme forms of cathepsin B in human osteoarthritic cartilage and cultured chondrocytes. Arthritis Rheum 44:1819-1831, 2001.
10. Borzì RM, Mazzetti I, Macor S, et al: Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritis. FEBS Lett 455:238-242, 1999.
11. Borzì RM, Mazzetti I, Cattini L, et al: Human chondrocyte express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines. Arthritis Rheum 43:1734-1741, 2000.
12. Borzì RM, Mazzetti I, Magagnoli G, et al: Growth-related oncogene alpha induction of apoptosis in osteoarthritis chondrocytes. Arthritis Rheum 46:3201-3211, 2002.
13. Burr DB, Schaffler MB: The involvement of subchondral mineralized tissues in osteoarthrosis: quantitative microscopic evidence. Microsc Res Tech 37:343-357, 1997.
14. Caplan AI: Mesenchymal stem cells. J Orthop Res 9:641-650, 1991.
15. Caterson B, Flannery CR, Hughes CE, Little CB: Mechanisms involved in cartilage proteoglycan catabolism. Matrix Biol 19:333-344, 2000.
16. Dejardin E, Droin NM, Delhase M, et al: The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways. Immunity 17:525-535, 2002.
17. Delhase M, Hayakawa M, Chen Y, Karin M: Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 284:309-313, 1999.
18. Dequeker J, Mokassa L, Aerssens J, Boonen S: Bone density and local growth factors in generalized osteoarthritis. Microsc Res Tech 37:358-371, 1997.
19. Dieppe P, Cushnaghan J, Young P, Kirwan J: Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy. Ann Rheum Dis 52:557-563, 1993.
20. Evans CH: Gene therapies for osteoarthritis. Curr Rheumatol Rep 6:31-40, 2004.
21. Fernandes JC, Martel-Pelletier J, Pelletier JP: Gene therapy for osteoarthritis. New perspectives for the twenty-first century. Clin Orthop 379(Suppl):S262-S272, 2000.
22. Funakoshi-Tago M, Sonoda Y, Tanaka S, et al: Tumor Necrosis Factor-induced Nuclear Factor κB activation is impaired in focal adhesion kinase-deficient fibroblasts. J Biol Chem 278:29359-29365, 2003.
23. Ghosh S, Karin M: Missing pieces in the NF-kappaB puzzle. Cell 109(Suppl):S81-S96, 2002.
24. Goldring MB: The role of the chondrocyte in osteoarthritis. Arthritis Rheum 43:1916-1926, 2000.
25. Granet C, Bouthar N, Vico L, Alexandre C, Lafage-Proust MH: MAPK and SRC-kinases control EGR-1 and NF-kappa B inductions by changes in mechanical environment in osteoblasts. Biochem Biophys Res Commun 284:622-631, 2001.
26. Grassi F, Cristino S, Toneguzzi S, et al: CXCL12 chemokine upregulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients. J Cell Physiol 199:244-251, 2004.
27. Haüselmann HJ, Flechtenmacher J, ichal L: The superficial layer of human articular cartilage is more susceptible to interleukin-1-induced damage than the deeper layers. Arthritis Rheum 39:478-488, 1996.
28. Heller RA, Schena M, Chai A, et al: Discovery and analysis of inflammatory disease- related genes using cDNA microarrays. Proc Natl Acad Sci USA 94:2150-2155, 1997.
29. Hering TM: Regulation of chondrocyte gene expression. Front Biosci 4:d743-d761, 1999.
30. Hilal G, Martel-Pelletier J, Pelletier JP, Duval N, Lajeunesse D: Abnormal regulation of urokinase plasminogen activator by insulin-like growth factor 1 in human osteoarthritic subchondral osteoblasts. Arthritis Rheum 42:2112-2122, 1999.
31. Honorati MC, Bovara M, Cattini L, Piacentini A, Facchini A: Contribution of interleukin 17 to human cartilage degradation and synovial inflammation in osteoarthritis. Osteoarthritis Cartilage 10:799-807, 2002.
32. Kanbe K, Takagishi K, Chen Q: Stimulation of matrix metalloprotease 3 release from human chondrocytes by the interaction of stromal cell-derived factor 1 and CXC chemokine receptor 4. Arthritis Rheum 46:130-137, 2002.
33. Karin M: How NF-κB is activated: the role of the IκB (IKK) complex. Oncogene 18:6867-6874, 1999.
34. Karin M, Cao Y, Greten FR, Li ZW: NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2:301-310, 2002.
35. Klimatcheva E, Rosenblatt JD, Planelles V: Lentiviral vectors and gene therapy. Front Biosci 4:d481-d496, 1999.
36. Korver GH, van de Stadt RJ, van Kampen GP, van der Korst JK: Composition of proteoglycans synthesized in different layers of cultured anatomically intact cartilage. Matrix 6:394-401, 1990.
37. Kostoulas G, Lang A, Nagase H, Baici A: Stimulation of angiogenesis through cathepsin B inactivation of the tissue inhibitors of matrix metalloproteinases. FEBS Lett 455:286-290, 1999.
38. Kuettner KE, Pauli BU, Gall G, Memoli VA, Schenk RK: Synthesis of cartilage matrix by mammalian chondrocytes in vitro. I. Isolation, culture characteristics, and morphology. J Cell Biol 93:743-750, 1982.
39. Kuettner KE, Thonar EJ-M: Osteoarthritis and Related Disorders: Cartilage Integrity and Homeostasis. In Klippel JH, Dieppe PA (eds). Rheumatology. London, Mosby International, p. 8.6.1, 1998.
40. Kunkel SL, Lukacs N, Kasama T, Strieter RM: The role of chemokines in inflammatory joint disease. J Leukoc Biol 59:6-12, 1996.
41. Lajeunesse D, Reboul P: Subchondral bone in osteoarthritis: A biologic link with articular cartilage leading to abnormal remodeling. Curr Opin Rheumatol 15:628-633, 2003.
42. Li X, Massa PE, Hanidu A, et al: IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program. J Biol Chem 277:45129-45140, 2002.
43. Lisignoli G, Toneguzzi S, Pozzi C, et al: Proinflammatory cytokines and chemokine production and expression by human osteoblasts isolated from patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 26:791-799, 1999.
44. Lisignoli G, Toneguzzi S, Pozzi C, et al: Chemokine expression by subchondral bone marrow stromal cells isolated from osteoarthritis (OA) and rheumatoid arthritis (RA) patients. Clin Exp Immunol 116:371-378, 1999.
45. Lisignoli G, Piacentini A, Toneguzzi S, et al: Osteoblasts and stromal cells isolated from femora in rheumatoid arthritis (RA) and osteoarthritis (OA) patients express IL-11, leukaemia inhibitory factor and oncostatin M. Clin Exp Immunol 119:346-353, 2000.
46. Lisignoli G, Toneguzzi S, Grassi F, et al: Different chemokines are expressed in human arthritis bone biopsies: IFN-γ and IL-6 differently modulate IL-8, MCP-1 and RANTES production by arthritic osteoblasts. Cytokine 20:231-238, 2002.
47. Lisignoli G, Toneguzzi S, Piacentini A, et al: Human osteoblasts express functional CXC chemokine receptors 3 and 5: activation by their ligands, CXCL10 and CXCL13, significantly induces alkaline phosphatase and β-N- acetylhexosaminidase release. J Cell Physiol 194:71-79, 2003.
48. Lisignoli G, Toneguzzi S, Piacentini A, et al: Recruitment and proliferation of T lymphocytes is supported by IFNγ- and TNFα-activated human osteoblasts: involvement of CD54 (ICAM-1) and CD106 (VCAM-1) adhesion molecules and CXCR3 chemokine receptor. J Cell Physiol 198:388-398, 2004.
49. Liu J, Shikhman AR, Lotz MK, Wong CH: Hexosaminidase inhibitors as new drug candidates for the therapy of osteoarthritis. Chem Biol 8:701-711, 2001.
50. Loeser RF, Carlson CS, McGee PM: Expression of beta 1 integrins by cultured articular chondrocytes and in osteoarthritic cartilage. Exp Cell Res 217:248-257, 1995.
51. Loeser RF: Chondrocyte integrin expression and function. Biorheology 37:109-116, 2000.
52. Loetscher P, Moser B: Homing chemokines in rheumatoid arthritis. Arthritis Res 4:233-236, 2002.
53. Lotz M, Terkeltaub R, Villiger PM: Cartilage and joint inflammation. Regulation of IL-8 expression by human articular chondrocytes. J Immunol 148:466-473, 1992.
54. Lotz M, Hashimoto S, Kuhn K: Mechanisms of chondrocyte apoptosis. Osteoarthritis Cartilage 7:389-391, 1999.
55. Madry H, Cucchiarini M, Terwilliger EF, Trippel SB: Recombinant adeno-associated virus vectors efficiently and persistently transduce chondrocytes in normal and osteoarthritic human articular cartilage. Hum Gene Ther 14:393-402, 2003.
56. Mansell JP, Bailey AJ: Abnormal cancellous bone collagen metabolism in osteoarthritis. J Clin Invest 101:1596-1603, 1998.
57. Martel-Pelletier J, Di Battista JA, Lajeunesse D, Pelletier JP: IGF/IGFBPj axis in cartilage and bone in osteoarthritis pathogenesis. Inflamm Res 47:90-100, 1998.
58. Mazzetti I, Magagnoli G, Paoletti S, et al: A role for chemokines in the induction of chondrocyte phenotypic modulation. Arthritis Rheum 50:112-122, 2004.
59. Mellado M, Rodriguez-Frade JM, Manes S, Martinez-A C: Chemokine signaling and functional responses: The role of receptor dimerization and TK pathway activation. Annu Rev Immunol 19:397-421, 2001.
60. Merz D, Liu R, Johnson K, Terkeltaub R: IL-8/CXCL8 and growth-related oncogene alpha/CXCL1 induce chondrocyte hypertrophic differentiation. J Immunol 171:4406-4415, 2003.
61. Mital MA, Millington PF: Osseous pathway of nutrition to articular cartilage of the human femoral head. Lancet 1:842, 1970.
62. Mokonjimobe E, Hecquet C, Robic D, Bourbouze R, Adolphe M: Hexosaminidase and alkaline phosphatase activities in articular chondrocytes and relationship to cell culture conditions. Experientia 48:396-398, 1992.
63. Mort JS, Magny MC, Lee ER: Cathepsin B: an alternative protease for the generation of an aggrecan 'metalloproteinase' cleavage neoepitope. Biochem J 335:491-494, 1998.
64. Murakami S, Lefebvre V, de Crombrugghe B: Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-alpha. J Biol Chem 275:3687-3692, 2000.
65. Murphy PM, Baggiolini M, Charo IF, et al: International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52:145-176, 2000.
66. Nagase H, Woessner Jr JF: Matrix metalloproteinases. J Biol Chem 274:491-494, 1999.
67. Onuffer JJ, Horuk R: Chemokines, chemokine receptors and small-molecule antagonists: Recent developments. Trends Pharmacol Sci 23:459-467, 2002.
68. Patel DD, Koopmann W, Imai T, et al: Chemokines have diverse abilities to form solid phase gradients. Clin Immunol 99:43-52, 2001.
69. Pomerantz JL, Baltimore D: Two pathways to NF-κB. Mol Cell 10:693-694, 2002.
70. Proudfoot AE: Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol 2:106-115, 2002.
71. Pullig O, Weseloh G, Ronneberger DL, Kakonen SM, Swoboda B: Chondrocyte differentiation in human osteoarthritis: Expression of osteocalcin in normal and osteoarthritic cartilage and bone. Calcif Tissue Int 67:230-240, 2000.
72. Pulsatelli L, Dolzani P, Piacentini A, et al: Chemokine production by human chondrocytes. J Rheumatol 26:1992-2001, 1999.
73. Radin EL, Rose RM: Role of subchondral bone in the initiation and progression of cartilage damage. Clin Orthop 213:34-40, 1986.
74. Ranganathan AC, Nelson KK, Rodriguez AM, et al: Manganese Superoxide dismutase signals matrix metalloproteinase expression via H202-dependent ERK1/2 activation. J Biol Chem 276:4264-4270, 2001.
75. Recklies AD, Golds EE: Induction of synthesis and release of interleukin-8 from human articular chondrocytes and cartilage explants. Arthritis Rheum 35:1510-1519, 1992.
76. Rutz S, Scheffold A: Towards in vivo application of RNA interference - new toys, old problems. Arthritis Res Ther 6:78-85, 2004.
77. Sandell LJ, Aigner T: Articular cartilage and changes in arthritis. An introduction: Cell biology of osteoarthritis. Arthritis Res 3:107-113, 2001.
78. Shikhman AR, Brinson DC, Lotz M: Profile of glycosaminoglycan-degrading glycosidases and glycoside sulfatases secreted by human articular chondrocytes in homeostasis and inflammation. Arthritis Rheum 43:1307-1314, 2000.
79. Sizemore N, Lerner N, Dombrowski N, Sakurai H, Stark GR: Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B. J Biol Chem 277:3863-3869, 2002.
80. Sokoloff L: Microcracks in the calcified layer of articular cartilage. Arch Pathol Lab Med 117:191-195, 1993.
81. Summers KL, O'Donnell JL, Hoy MS, et al: Monocyte-macrophage antigen expression on chondrocytes. J Rheumatol 22:1326-1334, 1995.
82. van der Wetering M, Oving I, Muncan V, et al: Specific inhibition of gene expression using a sytably integrated, inducible small-interfering RNA vector. EMBO Rep 4:609-615, 2003.
83. Vincenti MP, Brinckeroff CE: Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: Integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res 4:157-164, 2002.
84. Westacott CI, Webb GR, Warnock MG, Sims JV, Elson CJ: Alteration of cartilage metabolism by cells from osteoarthritic bone. Arthritis Rheum 40:1282-1291, 1997.
85. Yamamoto Y, Gaynor RB: Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J Clin Invest 107:135-142, 2001.
86. Yamamoto Y, Verma UN, Prajapati S, Kwak YT, Gaynor RB: Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. Nature 423:655-659, 2003.
87. Ye RD: Regulation of nuclear factor κB activation by G-protein-coupled receptors. J Leukoc Biol 70:839-848, 2001.
88. Yuan GH, Masuko-Hongo K, Sakata M, et al: The role of C-C chemokines and their receptors in osteoarthritis. Arthritis Rheum 44:1056-1070, 2001.